Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials (Q46670494)
scientific article published in January 2006
Language:
(P31) (Q13442814)
(P50) (Q66360703)
(Q104285976)
(P304) 231-242
(P407) (Q1860)
(P433) 1
(P478) 31
(P577) Sunday, January 1, 2006
(P921) (Q170304)
(Q1189783)
(Q349856)
(P1433) (Q2261280)
(P1476) "Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials" (language: en)
(P2093) E Paul Wileyto
Leonard H Epstein
Margaret Rukstalis
Freda Patterson
Vyga Kaufmann
Stephanie Restine
Larry Hawk
Ray Niaura
Wade Berrettini
(P2860) (Q28307335)
(Q36084926)
(Q51983317)
(Q40502624)
(Q43604755)
(Q44468790)
(Q29619737)
(Q28205599)
(Q35784527)
(Q44851997)
(Q39486758)
(Q47732174)
(Q44941663)
(Q29615435)
(Q39556613)
(Q44440058)
(Q44839167)
(Q48770780)
(Q42622345)
(Q34963561)
(Q36002163)
(Q44049031)
(Q44626401)
(Q44344781)
(Q28262025)
(Q44692227)
(Q29301836)
(Q26778378)
(Q46439277)
(Q33906823)
(Q28378100)
(Q34722733)
(Q30233197)
(Q52275787)
(Q33709305)
(Q73532004)
(Q73804709)
(Q71683019)
(Q51081894)
(Q81250535)
(Q44005083)
(Q48563699)
other details
description scientific article published in January 2006

External Links